Pfizer's Singapore clinical research unit to shut down

The planned move out will be on mid-2013.

According to a BT article, Pfizer, the world's largest drugmaker, will close its clinical research unit at Raffles Hospital mid-way through its 10-year lease.

Singapore’s Pfizer Clinical Research Unit (PCRU) is one of three Phase I clinical research facilities operated by Pfizer globally. It was established in 2000 at Singapore General Hospital, initially with 31 beds.

With increasing demand for more trials covering different therapeutic areas to be conducted in Singapore, the facility expanded in June 2007 with 48 beds at Raffles Hospital.

In 2009, PCRU conducted nearly half of the total number of Phase I clinical trials in Singapore.

Besides Singapore, Pfizer has two other Phase I Clinical Research Units (CRU) located in Brussels, Belgium and New Haven, Connecticut, USA.

Read the full story here.

If you've been wondering whether SBR could work for your company — yes, probably.

A lot of the companies we partner with started as readers. They'd been following our coverage for a while, saw their own customers and competitors in it, and eventually asked the obvious question: could we do something with you? The answer is usually yes. The shape of it depends on what you're trying to do.

The options are broader than most people assume — thought leadership articles, sponsored content, industry summits across Southeast Asia, regional awards programmes, podcasts, and media placements in print and digital. Some partners use one channel; most use a mix. We figure out the right combination by starting with your brief, not with our rate card.

So if the question has been on your mind, here's the easy way to ask it.

We'll tell you honestly whether we can help, and how. It's a better use of everyone's time.

Book a meeting

| Or download the media kit (PDF)

240,000 senior readers quarterly in print Top 1,700 Singapore companies reached

7 markets across Southeast Asia